Search Results - "Naqvi, Syed Mujtaba Hussain"
-
1
1785-PUB: Dyslipidemia Management in Patients with the First Acute Coronary Event—A Retrospective Observational EMR-Based RWE Study
Published in Diabetes (New York, N.Y.) (23-06-2023)“…Backgroud: The understanding of the current state of evidence-based lipid management after ACS is critical for improving outcomes after the first coronary…”
Get full text
Journal Article -
2
1250-P: Clinical and Demographic Characteristics of Patients with Coexistent Type 2 Diabetes, Hypertension, and Dyslipidemia—Results from the Largest Retrospective EMR Study from India
Published in Diabetes (New York, N.Y.) (20-06-2023)“…Introduction: Common manifestations of end-organ damage due to diabetes, dyslipidemia and hypertension, predispose patients to develop cardiovascular diseases…”
Get full text
Journal Article -
3
Clinical and Demographic Characteristics of Patients with Coexistent Hypertension, Type 2 Diabetes Mellitus, and Dyslipidemia: A Retrospective Study from India
Published in Drugs -- real world outcomes (01-03-2024)“…Background Coexisting hypertension, type 2 diabetes mellitus (T2DM), and dyslipidemia (triple disease) can lead to greater risk of cardiovascular morbidity and…”
Get full text
Journal Article -
4
Novel Methods and Regulation on Electronic Data Collection in Clinical Trials
Published in Journal of clinical and diagnostic research (01-03-2018)“…The data collection is a pivotal part of clinical studies and impacts how the data is managed and analysed and the outcome of the clinical research besides…”
Get full text
Journal Article -
5
Post-trial access
Published in Perspectives in clinical research (01-01-2013)Get full text
Journal Article -
6
Stable Angina Pectoris: A Review of Pathophysiology, Diagnosis, and Its Management
Published in Journal of the Association of Physicians of India (01-11-2024)“…India is at the cusp of an impending epidemic of cardiovascular diseases (CVD). It has been triggered by rapid urbanization, industrialization, and…”
Get full text
Journal Article -
7
Efficacy and Safety of Novel Formulation of Clobetasol Propionate 0.025% Cream in Indian Moderate-to-Severe Psoriasis Patients: Phase-2a, Randomized 3-Arm Study
Published in Dermatology and therapy (01-10-2021)“…Introduction Clobetasol propionate (0.05% standard dose formulation), a topical corticosteroid, leads to systemic side-effects like…”
Get full text
Journal Article